Author

Liron Bassali

Augmanity Nano Ltd. (Israel)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Synthetic Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

Almogit Abu-Horowitz· 2 shared Ido BacheletiD· 2 shared Adva Levy-Zamir· 1 shared Adva Zamir· 1 shared Alexander Rosenberg· 1 shared Anastasia Paz· 1 shared Anastasia Shapiro· 1 shared Avichai ShimoniiD· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSynthetic Biology

Almogit Abu-Horowitz

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

An antiviral self-replicating molecular heterotroph

Anastasia Shapiro, Alexander Rosenberg, Adva Levy-Zamir, Liron Bassali, Shmulik Ittah, Almogit Abu-Horowitz, Ido Bachelet

This paper describes a molecular machine that digests viral RNA and uses it to replicate itself in cells, effectively suppressing viral propagation.

bioRxiv · Aug 12, 2020 · PreprintSynthetic Biology

Discovery of tumoricidal DNA oligonucleotides by effect-directed in-vitro evolution

Noam Mamet, Yaniv Amir, Erez Lavi, Liron Bassali, Gil Harari, Itai Rusinek, Nir Skalka, Elinor Debby, Mor Greenberg, Adva Zamir, Anastasia Paz, Neria Reiss, Gil Loewenthal, Irit Mazza Avivi, Avichai Shimoni, , Ido Bachelet

This paper describes an in-vitro evolution platform for discovering DNA oligonucleotides with tumoricidal activity and selectivity, showing efficacy against chemotherapy-resistant tumors.

bioRxiv · Jun 16, 2019 · PreprintSynthetic Biology